Syntheses,Structures and Anticancer Activities of Two Tri(o-halobenzyl)tin Substituted Benzoates

Tri(o-chlorobenzyl)tin 2,4,6-trimethylbenzoate(1)and tri(o-bromobenzyl)tin salicylate(2)were synthesized and characterized by elemental analysis,1R spectroscopy...     

三(三烃硅基亚甲基)锡吡啶甲酸酯的合成和结构表征

三(三烃硅基亚甲基)锡吡啶甲酸酯的合成和结构表征;含硅有机锡化合物;合成;结构表征;生物活性     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P2₁/m,晶体学参数:a=0.584 03(4) nm,b=1.966 37(14) nm,c=0.856 46 (5) nm, β=95.138(3), V=0.979 62(11) nm³,Z=2,D_c=1.735 g·cm^-3,μ(Mo Kα)=14.53 cm^-1,F(000)=524,R₁=0.043 7,wR₂=0.1232。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12) nm,b=1.167 41(8) nm,c= 1.539 41(11) nm,β=116.615(10)°,V=2.718 9(3) nm³,Z=4,D_c=1.424 g·cm^-3,μ(Mo Kα)=9.67cm^-1,F(000)=1 176,R₁=0.017 5,wR₂=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

三(3,5-二氟苄基)氯化锡和四(邻氯苄基)锡的合成、晶体结构及量子化学

3,5-二氟苄基氯和邻氯基苄基氯在适当的溶剂中与锡粉反应,合成了三（3,5-二氟苄基）氯化锡（1）和四（邻氯苄基）锡（2）,经X射线衍射方法测定了新化合物的晶体结构。化合物1属单斜晶系,空间群为C2/c,晶体学参数：a=1.858 33（11）nm,b=1.140 98（7）nm,c=2.690 06（16）nm,β=109.288（10）°,V=5.383 6（6）nm³,Z=8,D_c=1.532 g·cm^-3,μ（Mo Kα）=13.61 cm^-1,F（000）=2 480,R₁=0.085 1,wR₂=0.168 1。化合物2属单斜晶系,空间群为P2₁/m,晶体学参数：a=0.585 54（5）nm,b=1.969 74（18）nm,c=0.857 86（8）nm,β=95.204 0（10）°,V=0.985 34（15）nm³,Z=2,D_c=1.805 g·cm^-3,μ（Mo Kα）=14.91 cm^-1,F（000）=524,R₁=0.054 0,wR₂=0.163 9;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了化合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了化合物的热稳定性。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P21/m,晶体学参数:a=0.584 03(4)nm,b=1.966 37(14)nm,c=0.856 46(5)nm,β=95.138(3),V=0.979 62(11)nm3,Z=2,Dc=1.735 g·cm-3,μ(Mo Kα)=14.53 cm-1,F(000)=524,R1=0.043 7,w R2=0.123 2。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12)nm,b=1.167 41(8)nm,c=1.539 41(11)nm,β=116.615(10)°,V=2.718 9(3)nm3,Z=4,Dc=1.424 g·cm-3,μ(Mo Kα)=9.67cm-1,F(000)=1 176,R1=0.017 5,w R2=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

Synthesis, Crystal Structure and Quantum Chemistry Study of Tri（o-bromobenzyl）tin Ferrocenecarboxylate

A novel complex tri(o-bromobenzyl)tin ferrocenecarboxylate has been synthesized and its crystal structure was determined by X-ray diffraction. It belongs to orthorhombic, space group Pbca with a = 1.1340(3), b = 1.7823 (4), c = 3.0119(8) nm, V = 6.088(3) nm3, Mr = 857.81, Z = 8, Dc = 1.872 g/cm3, μ(MoKα) = 52.63 cm-1, F(000) = 3328, R = 0.0683 and wR = 0.1057. The tin atom adopts a distorted tetrahedral coordination geometry. Further studies on the title com- plex have been performed with quantum chemistry calculation at the Lanl2dz basis set level using G98W package. The stability of the complex, some frontier molecular orbital energies and com- position characteristics of some frontier molecular orbitals have been investigated.     

三(邻溴苄基)溴化锡和四(对溴苄基)锡的合成及结构研究

邻溴苄基溴或对溴苄基溴与锡反应合成三(邻溴苄基)溴化锡(1)和四(对溴苄基)锡(2).经X射线方法测定了新化合物的晶体结构.晶体结构1属斜方六面体晶系,空间群为R-3,晶体学参数:a=1.3389(3) nm, b=1.3389(3) nm, c=2.1896(8) nm, V=3.3993(16) nm3, Z=6, Dx=2.077 Mg·m-3, μ(Mo Kα)=81.83 cm-1, F(000)=2004, R1=0.0477, wR2=0.1372;晶体结构2属正交晶系,空间群为Fdd2,晶体学参数:a=2.1027(7) nm, b=2.3034(8) nm, c=1.1431(4) nm, V=5. 536(3) nm3, Z=8, Dx=1.917 Mg·m-3, μ(Mo Kα)=67.11 cm-1, F(000)=3056, R1=0.0358, wR2=0.0659.化合物1中Sn-C键长为0.2160(8) nm, Sn-Br键长为0.2491(3) nm;化合物2中Sn-C键长分别为0.2175和0.2178 nm.中心锡与亚甲基碳(或溴)原子构成畸型四面体.     

三(邻甲基苄基)锡和二(间氟苄基)锡硫代水杨酸酯配合物的合成、结构及性质

合成了三(邻甲基苄基)锡硫代水杨酸酯配合物(1)和一维链状二(间氟苄基)锡硫代水杨酸酯配合物(2),经元素分析、IR、NMR、X射线衍射等技术手段表征了其结构。配合物1属三斜晶系,空间群Pī,晶体学参数a=1.00221(5)nm,b=1.48934(8)nm,c=1.71789(9)nm,α=78.3120(10)°,β=85.6560(10)°,γ=80.2580(10)°,V=2.4725(2)nm~3,Z=2,Dc=1.371 g/cm~3,μ(Mo Kα)=10.91 cm~(-1),F(000)=1040,R_1=0.0439,wR_2=0.1119。配合物2属单斜晶系,空间群为P21/n,晶体学参数:a=1.17827(5)nm,b=2.11945(9)nm,c=1.55970(7)nm,β=93.4510(10)°,V=3.8880(3)nm~3,Z=4,Dc=1.671 g/cm~3,μ(Mo Kα)=14.53 cm~(-1),F(000)=1936,R1=0.0323,wR2=0.0927。配合物1中锡原子呈四配位畸变四面体构型,配合物2中锡原子呈五配位畸变三角双锥构型。配合物1和2分别在152和195℃下稳定,电化学性质不可逆,对人体癌细胞Colo205、Hep G2、MCF-7、Hela和NCI-H460具有体外抗癌活性,配合物2的抗癌活性远大于配合物1。     

氢键构筑网络结构的三正丁基锡羧酸酯的合成、结构及抗癌活性

微波辐射条件下, μ-氧-双(三正丁基锡)分别与二苯乙醇酸、2-氯烟酸反应, 合成了三正丁基锡羧酸酯(n-Bu)₃SnO₂CR(H₂O)[R:C(OH)Ph₂ (1), C₅NH₃Cl (2)]。经IR、1H和13C NMR、元素分析及X-射线单晶衍射表征结构。配合物1、2均属正交晶系, 空间群分别为Pbca和P2₁2₁2₁, 配基与中心锡原子均构成五配位畸变三角双锥构型。1和2晶体中, 存在着多种氢键作用, 分别连接扩展成二维和三维超分子网络。初步测试表明:1和2对人癌细胞Colo205、HepG2、MCF-7、Hela、NCI-H460增殖均有较强的抑制作用, 尤其对MCF-7、Hela、NCI-H460的抑制作用均大大优于卡铂, 且1的抗肿瘤活性更优于2。     

氢键构筑网络结构的三正丁基锡羧酸酯的合成、结构及抗癌活性

微波辐射条件下,μ-氧-双(三正丁基锡)分别与二苯乙醇酸、2-氯烟酸反应,合成了三正丁基锡羧酸酯(n-Bu)₃SnO₂CR(H₂O)[R:C(OH)Ph₂(1),C₅NH₃Cl(2)]。经IR、¹H和¹³C NMR、元素分析及X-射线单晶衍射表征结构。配合物1、2均属正交晶系,空间群分别为Pbca和P2₁2₁2₁,配基与中心锡原子均构成五配位畸变三角双锥构型。1和2晶体中,存在着多种氢键作用,分别连接扩展成二维和三维超分子网络。初步测试表明:1和2对人癌细胞Colo205、HepG2、MCF-7、Hela、NCI-H460增殖均有较强的抑制作用,尤其对MCF-7、Hela、NCI-H460的抑制作用均大大优于卡铂,且1的抗肿瘤活性更优于2。     

Syntheses, Crystal Structures and Antitumor Activities of Two Nicotinamides

Two nicotinamides have been synthesized by coupling aromatic amines with equimolar quantities of substituted nicotinic acids. Their structures have been determined by X-ray single-crystal diffraction. Compound 1, 6-chloro-N-(4-fluorophenyl)nicotinamide, crystallizes in the triclinic space group Pī with a = 4.2188(8) , b = 5.0687(10), c = 25.956(5), α = 86.38(3), β = 87.75(3), γ = 83.20(3)°, V = 549.75(19) 3 and Z = 2. Compound 2, N-(quinolin-3-yl)nico- tinamide, crystallizes in the monoclinic space group P21 with a = 8.5100(17), b = 6.4230(13), c = 11.620(2) , β = 110.39(3)°, V = 595.3(2) 3 and Z = 2. The cytotoxic activities of the two nicotinamides against five human tumor cell lines were tested in vitro. The results indicated that they showed a wide range of antitumor activities.     

三(3,5-二氟苄基)氯化锡和四(邻氯苄基)锡的合成、晶体结构及量子化学

3,5-二氟苄基氯和邻氯基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二氟苄基)氯化锡(1)和四(邻氯苄基)锡(2),经X射线衍射方法测定了新化合物的晶体结构。化合物1属单斜晶系,空间群为C2/c,晶体学参数:a=1.858 33(11)nm,b=1.140 98(7)nm,c=2.690 06(16)nm,β=109.288(10)°,V=5.383 6(6)nm3,Z=8,Dc=1.532 g·cm~(-3),μ(Mo Kα)=13.61 cm~(-1),F(000)=2 480,R1=0.085 1,wR~2=0.168 1。化合物2属单斜晶系,空间群为P21/m,晶体学参数:a=0.585 54(5)nm,b=1.969 74(18)nm,c=0.857 86(8)nm,β=95.204 0(10)°,V=0.985 34(15)nm3,Z=2,Dc=1.805 g·cm~(-3),μ(Mo Kα)=14.91 cm-1,F(000)=524,R1=0.054 0,wR_2=0.163 9;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了化合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了化合物的热稳定性。     

二(o-溴苄基)锡双(二乙基二硫代氨基甲酸)酯和二(o-氯苄基)锡双(吡咯啶二硫代氨基甲酸)酯的合成、结构及体外抗癌活性研究

二(o-溴苄基)二溴化锡和二(o-氯苄基)二氯化锡分别与N,N-二乙基二硫代氨基甲酸钠和吡咯啶二硫代氨基甲酸钠反应,合成了二(o-溴苄基)锡双(二乙基二硫代氨基甲酸)酯(1)和二(o-氯苄基)锡双(吡咯啶二硫代氨基甲酸)酯(2)。用X-射线单晶衍射测定了两个化合物的晶体结构,测试结果表明:化合物1的晶体为单斜晶系,空间群P21/c,晶体学参数a=1.827 36(4)nm,b=0.900 60(2)nm,c=1.988 41(5)nm,β=114.878 0(10)°,V=2.968 71(12)nm3,Z=4,Dc=1.690 g·cm-3,μ(Mo Kα)=38.50 cm-1,F(000)=1 496,R1=0.051 6,wR2=0.154 6。化合物2的晶体为单斜晶系,空间群C2/c,晶体学参数a=2.241 28(4)nm,b=0.818 78(2)nm,c=1.542 69(3)nm,β=106.787 0(10)°,V=2.710 37(10)nm3,Z=4,Dc=1.623 g·cm-3,μ(Mo Kα)=14.65 cm-1,F(000)=1 336,R1=0.022 9,wR2=0.056 5。晶体中锡原子呈六配位畸变八面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了配合物的热稳定性和体外抗癌活性。     

三(邻氟苄基）氯化锡和四(对氟苄基）锡的合成及结构研究

邻氟苄基氯或对氟苄基氯分别与锡反应合成三(邻氟苄基)氯化锡(1)和四(对氟 苄基)锡(2)．经X射线方法测定了新化合物的晶体结构．晶体结构1属单斜晶系，空 间群为P2(1)／n，晶体学参数：a＝0.5896(9)nm,b-1.262(2)nm,c=2.634(4)nm, V=1.959(5)nm^3,Z=4,Dx=1.632g/cm^3,μ（Mo Kα)=14.69cm^-1,F(000)=952, R1=0.0541,wR2=0.1280;晶体结构2属单余晶系，空间群为Cc,晶体学参数：α=1. 0778(6)nm,b=2.3312(14)nm,c=1.0888(7)nm,V=2.460(3)nm^3,Z=4,Dx=1. 499g/cm^2,μ(Mo Kα)=10.82cm^-1,F(000)=1112,R1=0.0302,wR2=0.0590.在化合 物1和2中Sn-C键长分别为0.2136-0.2148和0.2138-0.2180nm,Sn-Cl键长为0.2378 (4)nm,中心锡与亚甲基碳（氯）原子构成畸型四面体。     

μ-氧-双{三[邻氯(氟)苄基]锡}的合成、结构和量子化学研究

The tri(o-chlorobenzyl)tin chloride as well as the tri(o-fluorobenzyl)tin was treated with aqueous solution of NaOH to formed the μ-oxygen-bis[tri(o-chlorobenzyl)tin] and μ-oxygen-bis[tri(o-fluorobenzyl)tin], respectively. The crystal and molecular structures of compound were determined by X-ray diffraction. The crystal(1) belongs to triclinic space group P1 with a=1.0195(5), b=1.0951(6), c=1.0986(6)nm, α=118.250(7), β=104.923(7), γ=99.534(8)°, V=0.9827(9)nm³,Z=1, D_x=1.701g·cm^-3, μ(MoKα)=17.12cm^-1, F(000)=498, R₁=0.0680, wR₂=0.13014. The crystal(2) are triclinic, space group P1 with a=0.9635(3), b=1.0797(4), c=1.0852(3)nm, α =105.807(5), β=90.551(6), γ=116.382(5)°, V=0.9619(6)nm³, Z=2, D_x=1.595g·cm^-3, μ(MoKα)=13.62cm^-1, F(000)=458, R₁=0.0268, wR₂=0.0674. The bond lengths of Sn-C is 0.2128(9)～2.162(12)nm and 0.2155(4)～0.2162(3)nm, and the Sn-O is 0.1901nm and 0.19166(6)nm, respectively. The bond angle Sn-O-Sn is 180.0(0)°. The tin atom has a distorted tetrahedral geometry. The composition characteristics of some frontier molecular orbitals have been investigated by means of G98W package and taking Lanl2dz basis set. (1) CCDC:184751,(2) CCDC:187572.     

三(对氟苄基)氯化锡和三(对氟苄基)锡N,N-(1,4-亚丁基)氨荒酸酯的合成及晶体结构

合成了三(对氟苄基)氯化锡(1)和三(对氟苄基)锡N,N-(1,4-亚丁基)氨荒酸酯(2).通过元素分析、红外光谱和核磁共振氢谱对其结构进行了表征.用X射线单晶衍射测定了这两个化合物的晶体结构.化合物1为单斜晶系,空间群P21, a=0.8403(3) nm, b=0.5958(2) nm, c=2.0016(8) nm, β=97.052(6)°, Z=2, V=0.9945(7) nm3, Dc=1.608 g/cm3, μ=1.447 mm-1, R1=0.0397, wR2=0.0813.化合物2为单斜晶系,空间群P21/n, a=0.8786(9) nm, b=1.993(2) nm, c=1.5039(15) nm, β=103.548(15)°, Z=4, V=2.560(4) nm3, Dc=1.537 g/cm3, μ=1.197 mm-1, R1=0.0363, wR2=0.0796. 在1的晶体中,锡原子呈四配位畸变四面体构型;2的晶体中,锡原子则是五配位畸变三角双锥构型.     

μ-氧-双[三(对氟苄基)锡]的合成、表征及晶体结构

The μ-oxygen-bis[tri(p-fluorobenzyl)tin] was synthesized. The structure were characterized by elementary analysis, IR and ¹H NMR and the crystal structure were determined by X-ray single crystal diffraction. The crystal of the title compound belongs to rhombohedral with space group R, a=1.346 4(4), b=1.346 4(4), c=1.772 9(7) nm, α=90°, β=90°, γ=120°, Z=3, V=2.783 2(15) nm³, D_c=1.625 g·cm^-3, μ(Mo Kα)=1.408 mm^-1, S=1.088, F(000)=1 350, R₁=0.027 5, wR₂=0.065 9. In compound, the tin atom has a distorted tetrahedral coordination configuration. CCDC: 257079.     

二(对氯苄基)锡双吗啉氨荒酸酯和二(对氯苄基)氯化锡N,N-二乙基氨荒酸酯的合成、表征及晶体结构

利用二(对氯苄基)二氯化锡和吗啉氨荒酸钠、N, N-二乙基氨荒酸钠反应, 合成了二(对氯苄基)锡双吗啉氨荒酸酯C24H28Cl2N2O2S4Sn (Mr = 694.31) 1和二(对氯苄基)氯化锡N, N-二乙基氨荒酸酯C19H22Cl3N2S4Sn (Mr = 553.54) 2。用X-射线单晶衍射测定了这2个化合物的晶体结构, 测试结果表明:化合物1的晶体为单斜晶系, 空间群C2/c, a = 21.998(9), b = 6.469(3), c = 20.204(8) ,β= 94.444(6)o, Z = 4, V = 2866.3(19) 3, Dc = 1.609 g/cm3, m(MoKa) = 1.394 mm-1, F(000) = 1400, S = 0.955, (D/s)max = 0.000, R = 0.0389, wR = 0.0817。化合物2的晶体为单斜晶系, 空间群P21/c, a = 13.088(10), b = 9.304(7), c = 19.593(14) ,β=107.158(10)o, Z = 4, V = 2280(3) 3, Dc = 1.613 g/cm3, m(MoKa) = 1.660 mm-1, F(000) = 1104, S = 1.010, (D/s)max = 0.001, R = 0.0290, wR = 0.0651。在化合物1中, 锡原子呈六配位畸变八面体构型, 化合物2的锡原子则是五配位畸变三角双锥构型。     

三邻氯苄基和三邻氟苄基锡吡咯烷氨荒酸酯的合成及晶体结构

Tri(o-chlorbenzyl)tin dithiotetrahydropyrrolocarbamate 1 and tri(o-fluorbenzyl)tin dithiotetrahydropyrrolocar-bamate 2 were synthesized. Their structures were characterized by elementary analysis， IR and ¹H NMR and the crystal structures were determined by X-ray single crystal diffraction. The crystal 1 belongs to triclinic with space group ， a=0.9076(4)nm， b=1.0663(5)nm， c=1.5193(7)nm， α=75.811(6)°，β=89.344(6)°， γ=72.665(6)°， Z=2， V=1.3577(11)nm³， D_c=1.569g·cm^-3， μ=1.406mm^-1， F(000)=644， R=0.0282， wR=0.0617. The crystal 2 belongs to monoclinic with space group P2₁/c， a=1.355(2)nm， b=1.0143(16)nm， c=1.986(3)nm， β=109.94(2)°， Z=4， V=2.565(7)nm³， D_c=1.539g·cm^-3， μ=1.195mm^-1，F(000)=1200， R=0.0467， wR=0.0788. In the crystals of 1 and 2， the structures consist of discrete molecules containing five-coordinate tin atom in a distorted trigonal bipyramidal configuration. CCDC: 1， 213679; 2， 213680.